6533b7d5fe1ef96bd126528b

RESEARCH PRODUCT

Computational Analysis of Clinical and Molecular Markers and New Theranostic Possibilities in Primary Open-Angle Glaucoma

Javier Moreno-montañésJavier Moreno-montañésSilvia M. Sanz-gonzálezSilvia M. Sanz-gonzálezJose M. BolarinMar Valero-velloMaria D Pinazo-duranMaria D Pinazo-duranJavier Abellán-abenzaJose Javier Garcia-medinaJose Javier Garcia-medinaJose Javier Garcia-medinaVicente Zanon-morenoVicente Zanon-moreno

subject

Posterior Eye Segmentmedicine.medical_specialtytheranosticsprimary open-angle glaucomaOpen angle glaucomagenetic structuresGlaucomalcsh:MedicineVisual disabilityDiseaseArticlePathogenesis03 medical and health sciences0302 clinical medicineOphthalmologymedicineoxidative stressComputational analysisbusiness.industrypathogenesisNeurodegenerationlcsh:RapoptosisneurodegenerationGeneral Medicinemedicine.diseaseeye diseasesinflammation030221 ophthalmology & optometrysense organsbusiness030217 neurology & neurosurgery

description

Primary open-angle glaucoma (POAG) is a paramount cause of irreversible visual disability worldwide. We focus on identifying clinical and molecular facts that may help elucidating the pathogenic mechanisms of the disease. By using ophthalmological approaches (biomicroscopy, ocular fundus, optical coherence tomography, and perimetry) and experimental tests (enzyme-linked immunosorbent assay (ELISA), high performance liquid chromatography (HPLC), and Western blot/immunoblotting) directed to evaluate the oxidative stress, inflammation, apoptosis, and neurodegeneration processes, we gather information to build a network of data to perform a computational bioinformatics analysis. Our results showed strong interaction of the above players and its downstream effectors in POAG pathogenesis. In conclusion, specific risk factors were identified, and molecules involved in multiple pathways were found in relation to anterior and posterior eye segment glaucoma changes, pointing to new theranostic challenges for better managing POAG progression.

10.3390/jcm9093032http://europepmc.org/articles/PMC7564865